ICU Medical Announces Time of Fourth Quarter 2024 Earnings Conference Call
ICU Medical (Nasdaq: ICUI) has announced its schedule for the fourth quarter 2024 earnings release and conference call. The company will release Q4 2024 results on Thursday, February 27, 2025, at approximately 4:00 p.m. ET (1:00 p.m. PT), followed by a conference call at 4:30 p.m. ET (1:30 p.m. PT) on the same day.
Investors can access the call via telephone at (800) 445-7795 using conference ID 'ICUMED'. Additionally, a webcast will be available through the Investors tab on ICU Medical's website at www.icumed.com, with replay options available.
ICU Medical (Nasdaq: ICUI) ha annunciato il programma per la pubblicazione dei risultati del quarto trimestre 2024 e la relativa conferenza telefonica. L'azienda pubblicherà i risultati del Q4 2024 giovedì 27 febbraio 2025, alle ore 16:00 ET (13:00 PT), seguita da una conferenza telefonica alle 16:30 ET (13:30 PT) lo stesso giorno.
Gli investitori possono partecipare alla chiamata telefonicamente al numero (800) 445-7795 utilizzando l'ID conferenza 'ICUMED'. Inoltre, sarà disponibile un webcast tramite la sezione Investitori sul sito web di ICU Medical all'indirizzo www.icumed.com, con opzioni di riproduzione disponibili.
ICU Medical (Nasdaq: ICUI) ha anunciado su calendario para la publicación de resultados del cuarto trimestre de 2024 y la conferencia telefónica. La compañía publicará los resultados del Q4 2024 el jueves 27 de febrero de 2025, aproximadamente a las 4:00 p.m. ET (1:00 p.m. PT), seguida de una conferencia telefónica a las 4:30 p.m. ET (1:30 p.m. PT) del mismo día.
Los inversores pueden acceder a la llamada por teléfono al (800) 445-7795 utilizando el ID de conferencia 'ICUMED'. Además, estará disponible un webcast a través de la pestaña de Inversores en el sitio web de ICU Medical en www.icumed.com, con opciones de repetición disponibles.
ICU Medical (Nasdaq: ICUI)는 2024년 4분기 실적 발표 및 컨퍼런스 콜 일정을 발표했습니다. 회사는 2025년 2월 27일 목요일 오후 4:00 ET (오후 1:00 PT)에 4분기 2024년 실적을 발표하고, 같은 날 오후 4:30 ET (오후 1:30 PT)에 컨퍼런스 콜을 진행할 예정입니다.
투자자들은 (800) 445-7795로 전화하여 'ICUMED' 회의 ID를 사용하여 통화에 참여할 수 있습니다. 추가로, ICU Medical의 웹사이트 www.icumed.com의 투자자 탭을 통해 웹캐스트가 제공되며, 다시 듣기 옵션도 이용할 수 있습니다.
ICU Medical (Nasdaq: ICUI) a annoncé son calendrier pour la publication des résultats du quatrième trimestre 2024 et la conférence téléphonique qui suivra. L'entreprise publiera les résultats du Q4 2024 le jeudi 27 février 2025, à environ 16h00 ET (13h00 PT), suivie d'une conférence téléphonique à 16h30 ET (13h30 PT) le même jour.
Les investisseurs peuvent accéder à l'appel par téléphone au (800) 445-7795 en utilisant l'ID de conférence 'ICUMED'. De plus, un webcast sera disponible via l'onglet Investisseurs sur le site web d'ICU Medical à l'adresse www.icumed.com, avec des options de rediffusion disponibles.
ICU Medical (Nasdaq: ICUI) hat seinen Zeitplan für die Veröffentlichung der Ergebnisse des vierten Quartals 2024 und die anschließende Telefonkonferenz bekannt gegeben. Das Unternehmen wird die Q4 2024 Ergebnisse am Donnerstag, den 27. Februar 2025, um ca. 16:00 Uhr ET (13:00 Uhr PT) veröffentlichen, gefolgt von einer Telefonkonferenz um 16:30 Uhr ET (13:30 Uhr PT) am selben Tag.
Investoren können die Konferenz telefonisch unter (800) 445-7795 mit der Konferenz-ID 'ICUMED' erreichen. Darüber hinaus wird ein Webcast über den Investorenbereich der Website von ICU Medical unter www.icumed.com verfügbar sein, mit Wiederholungsoptionen.
- None.
- None.
SAN CLEMENTE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter 2024 earnings release and conference call.
The Company will release its fourth quarter 2024 results on Thursday, February 27, 2025 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Thursday, February 27, 2025. The call can be accessed at (800) 445-7795, conference ID “ICUMED”. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.
About ICU Medical
ICU Medical (Nasdaq: ICUI) is a global leader in infusion systems, infusion consumables and high-value critical care products used in hospital, alternate site and home care settings. Our team is focused on providing quality, innovation and value to our clinical customers worldwide. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical can be found at www.icumed.com.
CONTACT:
ICU Medical, Inc.
Brian Bonnell, Chief Financial Officer
(949) 366-2183
ICR, Inc.
John Mills, Managing Partner
(646) 277-1254
Source: ICU Medical, Inc.
FAQ
When will ICU Medical (ICUI) release its Q4 2024 earnings?
What time is ICU Medical's (ICUI) Q4 2024 earnings conference call?
How can investors access ICU Medical's (ICUI) Q4 2024 earnings call?
Will ICU Medical's (ICUI) Q4 2024 earnings call be available for replay?
